Comment
doi: 10.1016/j.schres.2011.03.002. Epub 2011 Apr 1.The facts of schizophrenia: a personal commentary
Affiliations
- PMID:21458240
- DOI: 10.1016/j.schres.2011.03.002
Item in Clipboard
Comment
The facts of schizophrenia: a personal commentary
William T Carpenter. Schizophr Res.2011 May.
Display options
Format
Display options
Format
No abstract available
Comment on
- Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview.Tandon R, Keshavan MS, Nasrallah HA.Tandon R, et al.Schizophr Res. 2008 Mar;100(1-3):4-19. doi: 10.1016/j.schres.2008.01.022.Schizophr Res. 2008.PMID:18291627Review.
- Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.Tandon R, Keshavan MS, Nasrallah HA.Tandon R, et al.Schizophr Res. 2008 Jul;102(1-3):1-18. doi: 10.1016/j.schres.2008.04.011. Epub 2008 Jun 2.Schizophr Res. 2008.PMID:18514488Review.
- Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology.Keshavan MS, Tandon R, Boutros NN, Nasrallah HA.Keshavan MS, et al.Schizophr Res. 2008 Dec;106(2-3):89-107. doi: 10.1016/j.schres.2008.07.020. Epub 2008 Sep 16.Schizophr Res. 2008.PMID:18799287Review.
- Schizophrenia, "just the facts" 4. Clinical features and conceptualization.Tandon R, Nasrallah HA, Keshavan MS.Tandon R, et al.Schizophr Res. 2009 May;110(1-3):1-23. doi: 10.1016/j.schres.2009.03.005. Epub 2009 Mar 27.Schizophr Res. 2009.PMID:19328655Review.
- Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future.Tandon R, Nasrallah HA, Keshavan MS.Tandon R, et al.Schizophr Res. 2010 Sep;122(1-3):1-23. doi: 10.1016/j.schres.2010.05.025. Epub 2010 Jul 23.Schizophr Res. 2010.PMID:20655178Review.
- "Just the facts": meandering in schizophrenia's many forests.Tandon R, Nasrallah HA, Keshavan MS.Tandon R, et al.Schizophr Res. 2011 May;128(1-3):5-6. doi: 10.1016/j.schres.2011.03.004. Epub 2011 Mar 30.Schizophr Res. 2011.PMID:21454056No abstract available.
Similar articles
- "Just the facts" of schizophrenia in the context of human evolution: commentary on Keshavan et al. (2011).Crow TJ.Crow TJ.Schizophr Res. 2011 Jul;129(2-3):205-7. doi: 10.1016/j.schres.2011.02.002. Epub 2011 May 5.Schizophr Res. 2011.PMID:21546215No abstract available.
- The legacy of "just the facts".MacDonald AW 3rd, Schulz SC.MacDonald AW 3rd, et al.Schizophr Res. 2011 Sep;131(1-3):1-3. doi: 10.1016/j.schres.2011.06.013. Epub 2011 Jul 6.Schizophr Res. 2011.PMID:21737247
- Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H, Hargarter L, Bierhoff HW, Brüne M.Juckel G, et al.Schizophr Res. 2008 Sep;104(1-3):287-93. doi: 10.1016/j.schres.2008.04.037. Epub 2008 Jul 1.Schizophr Res. 2008.PMID:18595665
- Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview.Tandon R, Keshavan MS, Nasrallah HA.Tandon R, et al.Schizophr Res. 2008 Mar;100(1-3):4-19. doi: 10.1016/j.schres.2008.01.022.Schizophr Res. 2008.PMID:18291627Review.
- [hat facts today corroborate a psychogenetic theory of schizophrenia? A critical survey of the literature of the last 30 years].Kind H.Kind H.Psyche (Stuttg). 1965 Jun;19(3):188-218.Psyche (Stuttg). 1965.PMID:5320018Review.German.No abstract available.
Cited by
- Stratification by Sex and Hormone Level When Contrasting Men and Women in Schizophrenia Trials Will Improve Personalized Treatment.Seeman MV, González-Rodríguez A.Seeman MV, et al.J Pers Med. 2021 Sep 18;11(9):929. doi: 10.3390/jpm11090929.J Pers Med. 2021.PMID:34575706Free PMC article.Review.
- Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, Deakin JF, Dourish CT, Koychev I, McMullen K, Migo EM, Perry C, Wilkinson L, Morris R, Williams SC, Ettinger U.Schmechtig A, et al.Psychopharmacology (Berl). 2013 May;227(2):331-45. doi: 10.1007/s00213-013-2973-4. Epub 2013 Feb 22.Psychopharmacology (Berl). 2013.PMID:23430159Clinical Trial.
- Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?Borovcanin MM, Jovanovic I, Radosavljevic G, Pantic J, Minic Janicijevic S, Arsenijevic N, Lukic ML.Borovcanin MM, et al.Front Psychiatry. 2017 Nov 6;8:221. doi: 10.3389/fpsyt.2017.00221. eCollection 2017.Front Psychiatry. 2017.PMID:29163240Free PMC article.Review.
- Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.O'Tuathaigh CMP, Moran PM, Zhen XC, Waddington JL.O'Tuathaigh CMP, et al.Br J Pharmacol. 2017 Oct;174(19):3173-3190. doi: 10.1111/bph.13938. Epub 2017 Aug 3.Br J Pharmacol. 2017.PMID:28667666Free PMC article.Review.
- Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.Dalton GL, Floresco SB, Phillips AG.Dalton GL, et al.Psychopharmacology (Berl). 2021 Apr;238(4):1069-1085. doi: 10.1007/s00213-020-05754-y. Epub 2021 Jan 11.Psychopharmacology (Berl). 2021.PMID:33432392
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical